These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3631114)

  • 41. A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase.
    Fujiwara H; Onodera T; Tanaka M; Fujiwara T; Wu DJ; Kawai C; Hamashima Y
    Circulation; 1986 Apr; 73(4):749-57. PubMed ID: 3948373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prehospital thrombolysis in acute myocardial infarction.
    Schofer J; Büttner J; Geng G; Gutschmidt K; Herden HN; Mathey DG; Moecke HP; Polster P; Raftopoulo A; Sheehan FH
    Am J Cardiol; 1990 Dec; 66(20):1429-33. PubMed ID: 2251987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
    Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
    J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple coronary thrombosis in a patient with thrombocytosis.
    Hamada Y; Matsuda Y; Fujii B; Ohno H; Takashiba K; Ebihara H; Hyakuna E
    Clin Cardiol; 1989 Dec; 12(12):723-4. PubMed ID: 2612078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
    Kawai C; Yui Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
    [No Abstract]   [Full Text] [Related]  

  • 47. The severity of residual coronary stenosis immediately after thrombolytic therapy does not influence the size of later left ventricular asynergic area.
    Fukunaga T; Hanada Y; Koiwaya Y; Eto T
    Clin Cardiol; 1994 Nov; 17(11):589-95. PubMed ID: 7834932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study.
    Sun Y; Liu X; Guo L; Pang W; Guo X; Sun Z; Li Z; Cui X; Li H; Tao G; Wang L; Zhou C; Liu Y; Shan H; Wang M; Liu M; Li J; Yin L; Hu D
    Int J Cardiol; 2014 Mar; 172(2):326-31. PubMed ID: 24525155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary thrombolysis and endothelin-1 release.
    Tomoda H
    Angiology; 1993 Jun; 44(6):441-6. PubMed ID: 8503509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intracoronary thrombolytic treatment with urokinase in myocardial infarct: clinical angiographic findings and effects on left ventricular function].
    Ibba GV; Terrosu P; Franceschino V; Contini G; Frau G
    G Ital Cardiol; 1983 Aug; 13(8):75-84. PubMed ID: 6653959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 52. Pathogenesis of impending myocardial infarction and acute myocardial infarction: clinical and angiographic evaluation of coronary thrombosis as a precipitating factor.
    Katoh O; Gotoh K; Tateyama H; Suzuki K; Yasumura Y; Ohnishi S; Fujii K; Hamano Y; Fukui S; Minamino T
    Jpn Circ J; 1986 Feb; 50(2):188-97. PubMed ID: 3723781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)].
    Gulba DC; Bode C; Topp J; Höpp HW; Westhoff-Bleck M; Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1990 Apr; 79(4):279-85. PubMed ID: 2113330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
    Van de Werf F; Nobuhara M; Collen D
    Ann Intern Med; 1986 Mar; 104(3):345-8. PubMed ID: 3080936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of renokinase on the space velocity of coronary vein flow during systemic administration to patients with acute myocardial infarct].
    Terekhov VN; Bogatyrev IV; Makolkin VI; Syrkin AL; Bokarev IN
    Kardiologiia; 1988 May; 28(5):29-32. PubMed ID: 3411856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
    Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
    Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.
    de Boer MJ; Suryapranata H; Hoorntje JC; Reiffers S; Liem AL; Miedema K; Hermens WT; van den Brand MJ; Zijlstra F
    Circulation; 1994 Aug; 90(2):753-61. PubMed ID: 8044944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial damage after successful thrombolysis is associated with the duration of ST re-elevation at reperfusion.
    Ochiai M; Isshiki T; Hirose Y; Toyoizumi H; Oshima A; Kondo K; Sato T; Miyashita H; Tamura T
    Clin Cardiol; 1995 Jun; 18(6):324-8. PubMed ID: 7664506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myocardial infarction shortly after negative exercise test and reperfusion by intracoronary thrombolysis.
    Kurata C; Sakata K; Taguchi T; Kobayashi A; Yamazaki N
    Jpn Circ J; 1989 Nov; 53(11):1382-8. PubMed ID: 2621767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.